Health
BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute – EurekAlert
On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD bec…
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus. This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on the «Sputnik V» vaccine was published b…
-
Business20 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General17 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News8 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
Noosa News20 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success